Inventor · disambiguated record
Jiaxun Zhu
Also filed as: ZHU JIAXUN
2 granted patents·6 pending applications·1 citations·filing 2022–2025
32Inventor score
Top patents by PatentIndex Score
8 records- 0181US12304974B2Hyaluronic acid-collagen copolymer compositions and medical applications thereofSHANGHAI QISHENG BIOLOGICAL PREPARATION CO LTD·Filed 2022·Granted May 20, 2025·1 cites·21 claims
- 0263US2025376543A1Hyaluronic acid-collagen copolymer compositions and medical applications thereofSHANGHAI QISHENG BIOLOGICAL PREPARATION CO LTD·Filed 2025·Application pending·0 cites
- 0356US2025213697A1Injectable and/or sprayable, in situ polymerizable collagen compositions for sustained delivery of therapeuticsSHANGHAI QISHENG BIOLOGICAL PREPARATION CO LTD·Filed 2023·Application pending·0 cites
- 0455US11980699B2Cartilage regeneration using injectable, in situ polymerizable collagen compositions containing chondrocytes or stem cellsSHANGHAI QISHENG BIOLOGICAL PREPARATION CO LTD·Filed 2022·Granted May 14, 2024·0 cites·21 claims
- 0553US2023201418A1Soft tissue augmentation using injectable, neutral ph soluble collagen-glycosaminoglycan compositionsSHANGHAI QISHENG BIOLOGICAL PREPARATION CO LTD·Filed 2022·Application pending·0 cites
- 0651US2022362438A1Derivatized or Rapidly Polymerizing Collagen Compositions for Tissue Augmentation Containing Nonresorbable or Slowly Resorbable PolymersSHANGHAI QISHENG BIOLOGICAL PREPARATION CO LTD·Filed 2022·Application pending·0 cites
- 0751US2022362437A1Hyaluronic Acid Compositions Containing Slowly Resorbable PolymersSHANGHAI QISHENG BIOLOGICAL PREPARATION CO LTD·Filed 2022·Application pending·0 cites
- 0841US2025332225A1Injectable Neutral pH Collagen-Based Composition For MesotherapySHANGHAI QISHENG BIOLOGICAL PREPARATION CO LTD·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jiaxun Zhu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →